Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AJAX NYSE:ARA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAJAXAjax I$8.89$7.55▼$13.85$540.24MN/A1.21 million shs61,955 shsARAAmerican Renal Associates$11.52$11.50$5.57▼$11.98$397.94M1.11106,940 shs9,831 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAJAXAjax I0.00%0.00%0.00%0.00%0.00%ARAAmerican Renal Associates0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAJAXAjax IN/AN/AN/AN/AN/AN/AN/AN/AARAAmerican Renal AssociatesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAJAXAjax I 0.00N/AN/AN/AARAAmerican Renal Associates 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAJAXAjax IN/AN/AN/AN/AN/AN/AARAAmerican Renal Associates$822.52M0.48$1.69 per share6.80$2.59 per share4.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAJAXAjax IN/AN/A0.00N/AN/AN/AN/AN/AN/AARAAmerican Renal Associates-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAJAXAjax IN/AN/AN/AN/AN/AARAAmerican Renal AssociatesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAJAXAjax IN/AN/AN/AARAAmerican Renal Associates7.541.051.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAJAXAjax I52.68%ARAAmerican Renal Associates78.42%Insider OwnershipCompanyInsider OwnershipAJAXAjax IN/AARAAmerican Renal Associates9.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAJAXAjax I389.44 millionN/ANot OptionableARAAmerican Renal Associates4,97734.54 millionN/AOptionableARA, AJAX, SCSP, and CRES HeadlinesRecent News About These CompaniesInnovative Renal Care Sends Data Breach Letters Following Early 2024 IncidentFebruary 18, 2025 | jdsupra.comCKD Risk in West Africans Increases With One or Two APOL1 VariantsOctober 28, 2024 | renalandurologynews.comRBelow-Market Associates Believe They Deserve the Market Compensation. Are They Right?September 20, 2024 | law.comLAHA Publishes Scientific Statement on Renal Denervation for HypertensionAugust 23, 2024 | thecardiologyadvisor.comTUrinary CD4+ Cells Predict Renal Flares in ANCA-Associated VasculitisMay 9, 2024 | renalandurologynews.comRAmerican Renal Associates Notified Federal Regulators of Recent Data BreachMay 6, 2024 | jdsupra.comSugar, Uric Acid, and the Etiology of Diabetes and ObesityApril 26, 2024 | medscape.comMDialysis & Nephrology Digest - April 2024April 11, 2024 | jdsupra.comThe African American Study of Kidney Disease and Hypertension (AASK) Trial: What More Have We Learned?September 13, 2023 | medscape.comMPartners Are Frustrated With 'Zoom Associates.' But Will Threatening Their Bonuses Change That?September 8, 2023 | law.comLBayer's Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of CardiologyAugust 31, 2023 | benzinga.comARA Libertad to expose UK's 'disproportionate and provocative' military presence in MalvinasJuly 25, 2023 | en.mercopress.comEAs Layoffs Loom, How Much Control Do Associates Have Over Low Billable Hours?June 9, 2023 | law.comLBattling Self-Blame and Misconceptions About Renal Cancer as a Black AmericanMay 27, 2023 | everydayhealth.comEARA Forecast Projects Softening GrowthMay 25, 2023 | forconstructionpros.comFFirst-Year Associates Caught in the Crosshairs of Big Law's Latest LayoffsApril 11, 2023 | law.comLRenal Dysfunction in Cirrhosis: Diagnosis, Treatment, and PreventionMarch 22, 2023 | medscape.comMAKG Ara reviewMarch 19, 2023 | musicradar.comMRenal-Dose Dopamine: Myth or Ally in the Treatment of Acute Renal Failure?March 19, 2023 | medscape.comMPGI Urology Dept to do renal transplantsMarch 9, 2023 | tribuneindia.comTTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIgnore the Noise—Samsara Stock Is Still a Strong BuyBy Sam Quirke | June 12, 2025View Ignore the Noise—Samsara Stock Is Still a Strong BuyWill Warner Bros. Discovery’s Split Produce Double the Upside?By Jeffrey Neal Johnson | June 11, 2025View Will Warner Bros. Discovery’s Split Produce Double the Upside?Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big GainsBy Nathan Reiff | June 30, 2025View Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big GainsJPMorgan Chase: The Financial Fortress Built for Today's InvestorBy Jeffrey Neal Johnson | June 23, 2025View JPMorgan Chase: The Financial Fortress Built for Today's InvestorARA, AJAX, SCSP, and CRES Company DescriptionsAjax I NYSE:AJAXAjax I does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Ajax I was founded in 2020 and is based in New York, New York.American Renal Associates NYSE:ARAAmerican Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Is Fortinet Ready to Break Out After Months of Consolidation? AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Micron Insiders Sell But Investors Should Buy, Buy, Buy Believe the Hype? Can SoFi Maintain Its 3-Month Rally? Sizzling Insider Buys for Your High-Yield Watchlist Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
